Branded

Cumberland Pharmaceuticals is set to acquire Theravance Biopharma’s Vibativ, which is used to treat serious bacterial infections.

Sympazan is the first clobazam oral film formulation approved by the Food and Drug Administration, maker Aquestive Therapeutics said.

Bristol-Myers’ Empliciti provides a new immunotherapy combination for patients with relapsed or refractory multiple myeloma.

AcelRx's Dsuvia is indicated for acute pain severe enough to require an opioid analgesic for adults in medically supervised healthcare setting

Janssen's Invokana has received the Food and Drug Administration's blessing, making it the first oral diabetes treatment approved for cardiovascular events.

Jazz Pharmaceuticals' FDA approval of a new indication for Xyrem gives narcolepsy patients age seven years old and older a treatment for cataplexy, or excessive daytime sleepiness,

Mayne Pharma is planning to launch halobetasol foam, a potent corticosteroid for plaque psoriasis, in early 2019.

Xofluza is the first new antiviral flu treatment with a novel mechanism of action approved by the Food and Drug Administration in nearly 20 years.